Literature DB >> 19801986

GSK-3 is a master regulator of neural progenitor homeostasis.

Woo-Yang Kim1, Xinshuo Wang, Yaohong Wu, Bradley W Doble, Satish Patel, James R Woodgett, William D Snider.   

Abstract

The development of the brain requires the exquisite coordination of progenitor proliferation and differentiation to achieve complex circuit assembly. It has been suggested that glycogen synthase kinase 3 (GSK-3) acts as an integrating molecule for multiple proliferation and differentiation signals because of its essential role in the RTK, Wnt and Shh signaling pathways. We created conditional mutations that deleted both the alpha and beta forms of GSK-3 in mouse neural progenitors. GSK-3 deletion resulted in massive hyperproliferation of neural progenitors along the entire neuraxis. Generation of both intermediate neural progenitors and postmitotic neurons was markedly suppressed. These effects were associated with the dysregulation of beta-catenin, Sonic Hedgehog, Notch and fibroblast growth factor signaling. Our results indicate that GSK-3 signaling is an essential mediator of homeostatic controls that regulate neural progenitors during mammalian brain development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801986      PMCID: PMC5328673          DOI: 10.1038/nn.2408

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  39 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  The cell biology of neurogenesis.

Authors:  Magdalena Götz; Wieland B Huttner
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

Review 3.  The Akt-GSK-3 signaling cascade in the actions of dopamine.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2007-03-08       Impact factor: 14.819

4.  Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth.

Authors:  Woo-Yang Kim; Feng-Quan Zhou; Jiang Zhou; Yukako Yokota; Yan-Min Wang; Takeshi Yoshimura; Kozo Kaibuchi; James R Woodgett; E S Anton; William D Snider
Journal:  Neuron       Date:  2006-12-21       Impact factor: 17.173

5.  Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus.

Authors:  Jianhang Jia; Kazuhito Amanai; Gelin Wang; Jiong Tang; Bing Wang; Jin Jiang
Journal:  Nature       Date:  2002-03-24       Impact factor: 49.962

6.  GSK3beta activity modifies the localization and function of presenilin 1.

Authors:  Kengo Uemura; Akira Kuzuya; Yoshiharu Shimozono; Nobuhisa Aoyagi; Koichi Ando; Shun Shimohama; Ayae Kinoshita
Journal:  J Biol Chem       Date:  2007-03-27       Impact factor: 5.157

7.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.

Authors:  Yingwei Mao; Xuecai Ge; Christopher L Frank; Jon M Madison; Angela N Koehler; Mary Kathryn Doud; Carlos Tassa; Erin M Berry; Takahiro Soda; Karun K Singh; Travis Biechele; Tracey L Petryshen; Randall T Moon; Stephen J Haggarty; Li-Huei Tsai
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice.

Authors:  Q Ding; J Motoyama; S Gasca; R Mo; H Sasaki; J Rossant; C C Hui
Journal:  Development       Date:  1998-07       Impact factor: 6.868

View more
  181 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  ASPM regulates Wnt signaling pathway activity in the developing brain.

Authors:  Joshua J Buchman; Omer Durak; Li-Huei Tsai
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

4.  Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Authors:  David E Hurtado; Laura Molina-Porcel; Jenna C Carroll; Caryn Macdonald; Awo K Aboagye; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 5.  Initiating and growing an axon.

Authors:  F Polleux; William Snider
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04       Impact factor: 10.005

Review 6.  When pathways collide: collaboration and connivance among signalling proteins in development.

Authors:  Helen McNeill; James R Woodgett
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05-12       Impact factor: 94.444

7.  Cdc42 and Gsk3 modulate the dynamics of radial glial growth, inter-radial glial interactions and polarity in the developing cerebral cortex.

Authors:  Yukako Yokota; Tae-Yeon Eom; Amelia Stanco; Woo-Yang Kim; Sarada Rao; William D Snider; E S Anton
Journal:  Development       Date:  2010-12       Impact factor: 6.868

8.  Prenatal Alcohol Exposure Leads to Enhanced Serine 9 Phosphorylation of Glycogen Synthase Kinase-3β (GSK-3β) in the Hippocampal Dentate Gyrus of Adult Mouse.

Authors:  Lee Anna Cunningham; Jessie Newville; Lu Li; Phillip Tapia; Andrea M Allan; C Fernando Valenzuela
Journal:  Alcohol Clin Exp Res       Date:  2017-10-03       Impact factor: 3.455

Review 9.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

10.  MACF1 Controls Migration and Positioning of Cortical GABAergic Interneurons in Mice.

Authors:  Minhan Ka; Jeffrey J Moffat; Woo-Yang Kim
Journal:  Cereb Cortex       Date:  2017-12-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.